Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Adagene Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 17 | 14 | −3 |
| Shares | 12.3M | 11.2M | −1.07M (−8.7%) |
| Value | $34.3M | $33.7M | −$632.6K (−1.8%) |
New holders (2)
Institutions that held Adagene Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Catalina Capital Group, LLC | 16,752 | $51.3K | 0.02% |
| Royal Bank of Canada | 8,300 | $25.0K | 0.00% |
Sold out (5)
Institutions that held Adagene Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Artal Group S.A. | 1,020,000 | $2.86M |
| Prelude Capital Management, LLC | 28,620 | $80.1K |
| Millennium Management LLC | 15,181 | $42.8K |
| Citadel Advisors LLC | 12,995 | $36.6K |
| Advisor Group Holdings, Inc. | 538 | $1.51K |